WO2026094005 - COMPOSITIONS COMPRISING COLLAGENASE FOR USE IN TREATMENT OF PLANTAR FASCIITIS
National phase entry is expected:
Publication Number
WO/2026/094005
Publication Date
07.05.2026
International Application No.
PCT/IB2025/061181
International Filing Date
03.11.2025
Title **
[English]
COMPOSITIONS COMPRISING COLLAGENASE FOR USE IN TREATMENT OF PLANTAR FASCIITIS
[French]
COMPOSITIONS COMPRENANT UNE COLLAGÉNASE DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DE LA FASCIITE PLANTAIRE
Applicants **
ENDO BIOLOGICS LIMITED
Inventors
VIJAYAN, Saji
TURSI, James P.
ORTEGA, Luis A.
XIANG, Quinfang
Priority Data
63/716,153
04.11.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3996 | |
| EPO | Filing, Examination, Granting | 42763 | |
| Japan | Filing, Examination, Granting | 3609 | |
| South Korea | Filing, Examination, Granting | 4894 | |
| USA | Filing, Examination, Granting | 13990 |
Total:
69,252
Contact Us
Abstract[English]
Disclosed herein are methods of treating plantar fasciitis (PFA) in a subject comprising injecting a pharmaceutical formulation comprising collagenase into one or more plantar fasciitis affected areas in the subject's foot to thereby treat the plantar fasciitis.[French]
L'invention concerne des méthodes de traitement de la fasciite plantaire (FP) chez un sujet, comprenant l'injection d'une formulation pharmaceutique comprenant une collagénase dans une ou plusieurs zones affectées par la fasciite plantaire dans le pied du sujet, permettant ainsi de traiter la fasciite plantaire.